-
Amakem N.V., Diepenbeek, Belgium Business: Ophthalmic Hired: Steve Pakola as CMO, formerly CMO of ThromboGenics N.V.
Published on 5/21/2012
-
Antares Pharma Inc. (NYSE-A:AIS), Ewing, N.J. Business: Drug delivery Hired: LeRoux Jooste as SVP of pharmaceutical sales and marketing, formerly VP of commercial assessment and new product planning at Cephalon Inc., …
Published on 5/21/2012
-
China Biologic Products Inc. (NASDAQ:CBPO), Beijing, China Business: Hematology Transitioned: David Gao to CEO while remaining chairman; he succeeds Colin Zhao who remains as president
Published on 5/21/2012
-
Cytos Biotechnology AG (SIX:CYTN), Schlieren, Switzerland Business: Neurology, Inflammation, Cardiovascular Appointed: Joseph Anderson, partner at Abingworth; John Berriman, deputy chairman of Algeta ASA, as vice …
Published on 5/21/2012
-
DNAnexus Inc., Mountain View, Calif. Business: Bioinformatics Hired: Marc Olesen as president and COO, formerly SVP and general manager of network and cloud security at Intel Corp.'s McAfee Inc. subsidiary
Published on 5/21/2012
-
Epizyme Inc., Cambridge, Mass. Business: Cancer Hired: Eric Hedrick as CMO, formerly interim CMO and VP of oncology development at Pharmacyclics Inc.
Published on 5/21/2012
-
Insmed Inc. (NASDAQ:INSM), Monmouth Junction, N.J. Business: Musculoskeletal, Endocrine/Metabolic Transitioned: Donald Hayden to executive chairman from chairman; Randall Whitcomb, a director, to lead independent …
Published on 5/21/2012
-
IntegenX Inc., Pleasanton, Calif. Business: Microfluidics Hired: David Smith as COO, formerly EVP and CFO of Thoratec Corp.
Published on 5/21/2012
-
Medivir AB (SSE:MVIR B), Huddinge, Sweden Business: Infectious, Autoimmune, Musculoskeletal Hired: Henric Juserius as EVP of commercial operations, effective in August, formerly commercial director for the Nordic region…
Published on 5/21/2012
-
Myrexis Inc. (NASDAQ:MYRX), Salt Lake City, Utah Business: Cancer, Infectious Hired: Richard Brewer as president, CEO and a director, formerly CEO of Scios Inc., which Johnson & Johnson acquired; he replaces Robert …
Published on 5/21/2012
-
Newron Pharmaceuticals S.p.A. (SIX:NWRN), Bresso, Italy Business: Neurology Departing: Founder Luca Benatti as CEO and director, effective May 31; CFO Stefan Weber will become CEO
Published on 5/21/2012
-
Promedior Inc., Malvern, Pa. Business: Ophthalmic, Renal Hired: Suzanne Bruhn as president, CEO and a director, formerly SVP of strategic planning and program management for Shire plc's Shire Human Genetic Therapies Inc…
Published on 5/21/2012
-
Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China Business: Infectious Transitioned: Danny Chung to CFO from finance director; he replaces Interim CFO Nan Wang who remains as VP of business development and clinical …
Published on 5/21/2012
-
Synthetic Biologics Inc. (NYSE-A:SYN), Ann Arbor, Mich. Business: Autoimmune, Neurology, Musculoskeletal Appointed: Jeffrey Kraws, a director, as non-executive chairman
Published on 5/21/2012
-
Synthetic Biologics Inc. (NYSE-A:SYN), Ann Arbor, Mich. Business: Autoimmune, Neurology, Musculoskeletal Hired: Carol Reed as SVP of clinical and regulatory affairs, formerly CMO of Clinical Data Inc., which Forest …
Published on 5/21/2012
-
Vermillion Inc. (NASDAQ:VRML), Austin, Texas Business: Diagnostic Departing: Gail Page as president, CEO and a director
Published on 5/21/2012
-
Affitech A/S (CSE:AFFI), Copenhagen, Denmark Business: Cancer, Infectious, Antibodies Appointed: Aleksandr Shuster as chairman; and Yegor Vassetzky as vice chairman
Published on 5/14/2012
-
AMAG Pharmaceuticals Inc. (NASDAQ:AMAG), Lexington, Mass. Business: Hematology, Diagnostic Hired: William Heiden as president, CEO and a director, formerly president and CEO of GTC Biotherapeutics Inc.; Interim CEO …
Published on 5/14/2012
-
Bio-Matrix Scientific Group Inc. (OTCQB:BMSN; Pink:BMSN), La Mesa, Calif. Business: Transplant Hired: Christopher Mizer as president and COO of Bio-Matrix's Regen BioPharma Inc. subsidiary
Published on 5/14/2012
-
BioCancell Therapeutics Inc. (Tel Aviv:BICL), Jerusalem, Israel Business: Cancer Appointed: Aaron Schwartz, a director, as chairman
Published on 5/14/2012
-
BioCancell Therapeutics Inc. (Tel Aviv:BICL), Jerusalem, Israel Business: Cancer Transitioning: Jonathan Burgin, CFO, to CEO, effective June 1; he succeeds Uri Danon, who will depart
Published on 5/14/2012
-
BioMarin Pharmaceuticals Inc. (NASDAQ:BMRN), Novato, Calif. Business: Endocrine/Metabolic, Autoimmune, Cancer Hired: Dan Spiegelman as EVP and CFO, effective in June, formerly SVP and CFO at CV Therapeutics Inc., which …
Published on 5/14/2012
-
Celgene Corp. (NASDAQ:CELG), Summit, N.J. Business: Biopharmaceuticals Hired: Thomas Moriarty as general counsel and corporate secretary, formerly general counsel and corporate secretary at Express Scripts Inc.'s Medco …
Published on 5/14/2012
-
Celladon Corp., La Jolla, Calif. Business: Cardiovascular Appointed: Fouad Azzam, general partner at LSP Life Science Partners; and Todd Foley, managing director at MPM Capital
Published on 5/14/2012
-
DBV Technologies (Euronext:DBV), Bagneux, France Business: Inflammation, Diagnostic Hired: Charles Ruban as chief development officer effective May 30, formerly SVP of product development at Stallergenes S.A.
Published on 5/14/2012